Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?
Abstract
There is compelling experimental evidence that autologous skeletal muscle (SM) cell transplantation improves postinfarction cardiac function. This study assessed whether this benefit is still manifested in the clinically relevant setting of a treatment by ACE inhibitors.
